Process for the preparation of candesartan cilexetil
The invention relates to process for the preparation of Candesartan cilexetil. More particularly, it relates to the preparation of pure candesartan cilexetil by the deprotection of Trityl candesartan cilexetil with inorganic acids.
1. An improved process for the preparation of candesartan cilexetil comprising the steps of:
a. treating candesartan with trityl chloride to get trityl candesartan
b. reacting, the trityl candesartan with cilexetil chloride in dimethyl sulfoxide (DMSO) in the presence of a base to afford trityl candesartan cilexetil; and
c. deprotecting the trityl candesartan cilexetil in the presence of an inorganic acid selected from phosphoric acid and boric acid in a solvent medium at a temperature of 45° C. to reflux temperature to get candesartan cilexetil.
2. The process as claimed in claim 1 , wherein the trityl candesartan is prepared in methylene chloride (MDC) in the presence of triethyl amine.
3. The process as claimed in claim 1 , wherein the base utilized in step b) is an inorganic base selected from potassium carbonate and sodium carbonate.
4. The process as claimed in claim 1 , wherein in step b) the trityl candesartan cilexetil is isolated from ethanol.
5. The process as claimed in claim 1 , wherein the deprotection of trityl candesartan cilexetil is carried out by;
a. suspending the trityl candesartan cilexetil in ethanol;
b. adding at least one inorganic acid selected from phosphoric acid and boric acid;
c. maintaining the reaction mass at a temperature of 45° C. to reflux temperature;
d. concentrating the reaction mass to about ½ to ¼ of its original volume;
e. adding an antisolvent selected from the group of C5-C7 hydrocarbons; and
f. maintaining the mass at about 10° C. to 55° C. to get candesartan cilexitil.
6. The process as claimed in claim 1 , wherein the obtained candesartan cilexetil is further purified by dissolving in acetone and precipitation by an addition of water.
7. The process as claimed in claim 6 , wherein the obtained candesartan cilexetil is in the form of Type-C crystals.
8. The process of claim 5 wherein the antisolvent is selected from hexane and heptane.
9. The process of claim 5 wherein in step f) the mass is maintained at a temperature of about 15° C. to 30° C.